March 16, 2022
V-Bio Ventures’ Portfolio Company Precirix Raises EUR 80m in Series B to Advance its Pipeline of Precision Radiopharmaceuticals
V-Bio Ventures has announced the completion of a EUR 80m Series B round of it’s portfolio company Precirix NV led by new investors INKEF Capital, Jeito Capital and Forbion as co-leads.